相关实验视频
Updated: Jul 13, 2025

07:57
Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
4.0K
严重的高甘油三血症:现有和新兴的疗法
Waqas A Malick1, Ron Do2, Robert S Rosenson1
1Metabolism and Lipids Program, The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Pharmacology & therapeutics
|October 17, 2023
概括
严重的高甘油三血症 (sHTG) 是一种遗传疾病,增加了急性胰腺炎的风险. 针对apoc-III和ANGPTL3等特定蛋白质的新型疗法在sHTG和心血管事件中表现出更大的疗效.
科学领域:
- 生物化学 生物化学
- 遗传学 是一个遗传学.
- 心脏病学 心脏病学
背景情况:
- 严重的高甘油三血症 (sHTG),高甘油三水平≥500 mg/dL,是急性胰腺炎的重要危险因素.
- sHTG是由影响甘油三脂解的遗传缺陷引起的,包括家族性胆小菌血症综合征 (FCS) 和多因子胆小菌血症综合征 (MCS).
- 传统的sHTG治疗提供了有限的疗效,并没有减少心血管事件.
研究的目的:
- 审查sHTG及其相关风险的遗传基础.
- 探索开发和有效的新的,特定途径的治疗方法sHTG.
- 突出新疗法减少急性胰腺炎和心血管疾病事件的潜力.
主要方法:
- 审查与甘油三代谢有关的遗传发现.
- 分析新兴的治疗点,包括阿波利波蛋白C-III (apoC-III),血管类蛋白3 (ANGPTL3),血管类蛋白4 (ANGPTL4) 和纤维细胞生长因子-21 (FGF21).
- 评估这些新药在管理sHTG表型中的临床潜力.
主要成果:
- 遗传研究已经确定了参与甘油三脂解的关键蛋白质,以及它们在sHTG中的功能障碍.
- 与较旧的治疗方法相比,针对apoC-III,ANGPTL3,ANGPTL4和FGF21的新型治疗方法显示出更高的TG降低效率.
- 这些向疗法为管理各种sHTG表型提供了一个有希望的方法.
结论:
- 基因洞察力已经彻底改变了对sHTG的理解和治疗.
- 针对apoc-III和ANGPTL3等蛋白质的特定途径疗法在管理sHTG方面取得了重大进展.
- 新的治疗方法有望减少患有sHTG的患者急性胰腺炎和动脉样硬化心血管疾病事件的风险.
关键词:
类似于 ангиопоетин的3蛋白质血管蛋白类蛋白质 4 类似于血管蛋白质的蛋白质在C-III的阿波利波蛋白中.奇洛米克龙是什么意思脂蛋白脂酶是一种脂蛋白脂酶.富含三糖蛋白的脂蛋白是一种富含三糖蛋白的脂蛋白.三甲酸甘油三甲酸甘油是什么非常低密度的脂蛋白是非常低密度的脂蛋白.更多相关视频
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
676
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
676
Atherosclerosis III: Management
11
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
Overview of Lipid Metabolism
1.7K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.7K
Blood Studies for Cardiovascular System III: Serum Lipid Profile
168
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
168
Inflammatory Bowel Disease IV: Pharmacological Management
134
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
134
Diabetes: Management and Pharmacotherapy
290
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
290

